___________________
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 2003
LIGAND PHARMACEUTICALS INCORPORATED
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
000-20720
(Commission File Number)
10275 Science Center Drive,
San Diego, California
(Address of principal executive offices)
(858) 550-7500
(Registrant's telephone number, including area code)
77-0160744
(I.R.S. Employer Identification No.)
92121-1117
(Zip Code)
Item 5. Other Events
Attached hereto is the press release issued by the registrant on May 15, 2003.
Item 7. Exhibits
| Exhibit Number | Description |
| 99.1 | Press Release of the Company dated May 15, 2003 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned.
|
|
LIGAND PHARMACEUTICALS INCORPORATED
By: /S/ WARNER BROADDUS Name: Warner Broaddus Title: Vice President, General Counsel & Secretary |